6/24/2020 7:31:57 AM
La Jolla Pharma Agrees To Acquire Tetraphase Pharma
6/22/2020 6:08:58 AM
Tetraphase Gets Unsolicited Proposal From La Jolla Pharma; Determines La Jolla Proposal Is A "Superior Offer"
6/4/2020 10:11:01 AM
Melinta To Acquire Tetraphase For An Aggregate Of $39.0 Million In Cash Plus Addl $16.0 Mln In Cash
6/4/2020 9:34:53 AM
Melinta Therapeutics Plans To Acquire Tetraphase Pharmaceuticals
5/29/2020 8:46:22 AM
Tetraphase Reports Second Amendment To Merger Agreement With AcelRx
5/29/2020 8:34:43 AM
AcelRx Pharma Announces Revised Merger Agreement With Tetraphase
5/27/2020 8:58:43 PM
Tetraphase Reports Receipt Of Amended Melinta Proposal, Determination Of Superior Offer And Notice To AcelRx
5/21/2020 11:15:56 PM
Inari Medical Prices Upsized IPO Of 8.20 Mln Shares At $19.00/shr
5/21/2020 10:04:06 PM
Tetraphase Determines Melinta's Offer Superior Offer; May Terminates AcelRx Merger Deal
3/16/2020 7:38:48 AM
AcelRx Pharmaceuticals To Acquire Tetraphase In Stock
for Stock Transaction
3/12/2020 7:35:18 AM
Tetraphase Pharma Q4 Net Loss $11.4 Mln Or $2.75/Shr Vs Loss Of $21.5 Mln Or $8.00/Shr Last Year
9/26/2019 7:08:41 AM
Tetraphase Pharma Announces 1-for-20 Reverse Stock Split
6/24/2019 7:11:10 AM
Tetraphase Announces Presentation Of New Data On XERAVA And TP-6076
4/3/2019 8:05:43 AM
Tetraphase Pharma Presents Preclinical Data On TP-2846